RAPID IMPROVEMENT OF RUBEOSIS IRIDIS FROM A SINGLE BEVACIZUMAB (AVASTIN) INJECTION
Authors:
- J Garret MouserJMJ Garret Mouser
- Robert J. DerickRDRobert J. Derick
- 1 March 2006
- journal article
- case report
- Published by Wolters Kluwer Health in Retina
- Vol. 26 (3) , 354-356
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Intravitreal Bevacizumab for Choroidal Neovascularization and Cystoid Macular Edema: A Cost-Effective Treatment?Ophthalmic Surgery, Lasers and Imaging Retina, 2005
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular DegenerationOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein OcclusionOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathyJournal of Cellular and Molecular Medicine, 2005
- Targeting angiogenesis, the underlying disorder in neovascular age-related macular degenerationCanadian Journal of Ophthalmology, 2005
- THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASERetina, 2005